Adamantylglycine derivatives as inhibitors of dipeptidyl peptidase IV for the treatment of diabetes
申请人:Bristol-Myers Squibb Company
公开号:EP1997489A1
公开(公告)日:2008-12-03
The compounds of the present invention are adamantylglycine-based inhibitors of dipeptidyl peptidase IV (DPP-IV) and are useful for the treatment of diabetes and related diseases.
本发明的化合物是基于金刚烷基甘氨酸的二肽基肽酶 IV(DPP-IV)抑制剂,可用于治疗糖尿病及相关疾病。